{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:14:35Z","timestamp":1787915675461,"version":"build-2784847793"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"Importance<\/jats:title>With increasing medicinal and recreational cannabis legalization, there is a public health need for effective and unbiased evaluations for determining whether a driver is impaired due to \u03949<\/jats:sup>-tetrahydrocannabinol (THC) exposure. Field sobriety tests (FSTs) are a key component of the gold standard law enforcement officer\u2013based evaluations, yet controlled studies are inconclusive regarding their efficacy in detecting whether a person is under the influence of THC.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the classification accuracy of FSTs with respect to cannabis exposure and driving impairment (as determined via a driving simulation).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This double-blind, placebo-controlled parallel randomized clinical trial was conducted from February 2017 to June 2019 at the Center for Medicinal Cannabis Research, University of California, San Diego. Participants were aged 21 to 55 years and had used cannabis in the past month. Data were analyzed from August 2021 to April 2023.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Participants were randomized 1:1:1 to placebo (0.02% THC), 5.9% THC cannabis, or 13.4% THC cannabis smoked ad libitum.<\/jats:p><\/jats:sec>Main Outcome and Measures<\/jats:title>The primary end point was law enforcement officer determination of FST impairment at 4 time points after smoking. Additional measures included officer estimation as to whether participants were in the THC or placebo group as well as driving simulator data. Officers did not observe driving performance.<\/jats:p><\/jats:sec>Results<\/jats:title>The study included 184 participants (117 [63.6%] male; mean [SD] age, 30 [8.3] years) who had used cannabis a mean (SD) of 16.7 (9.8) days in the past 30 days; 121 received THC and 63, placebo. Officers classified 98 participants (81.0%) in the THC group and 31 (49.2%) in the placebo group as FST impaired (difference, 31.8 percentage points; 95% CI, 16.4-47.2 percentage points; P<\/jats:italic>\u2009&amp;lt;\u2009.001) at 70 minutes after smoking. The THC group performed significantly worse than the placebo group on 8 of 27 individual FST components (29.6%) and all FST summary scores. However, the placebo group did not complete a median of 8 (IQR, 5-11) FST components as instructed. Of 128 participants classified as FST impaired, officers suspected 127 (99.2%) as having received THC. Driving simulator performance was significantly associated with results of select FSTs (eg, \u22652 clues on One Leg Stand was associated with impairment on the simulator: odds ratio, 3.09; 95% CI, 1.63-5.88; P<\/jats:italic>\u2009&amp;lt;\u2009.001).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This randomized clinical trial found that when administered by highly trained officers, FSTs differentiated between individuals receiving THC vs placebo and driving abilities were associated with results of some FSTs. However, the high rate at which the participants receiving placebo failed to adequately perform FSTs and the high frequency that poor FST performance was suspected to be due to THC-related impairment suggest that FSTs, absent other indicators, may be insufficient to denote THC-specific impairment in drivers.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT02849587<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2023.2345","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T15:03:29Z","timestamp":1690988609000},"page":"914","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis"],"prefix":"10.1001","volume":"80","author":[{"given":"Thomas D.","family":"Marcotte","sequence":"first","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Umlauf","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grelotti","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Sones","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle F.","family":"Mastropietro","sequence":"additional","affiliation":[{"name":"Joint Doctoral Program in Clinical Psychology, San Diego State University\/University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Suhandynata","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Pathology, University of California, San Diego"},{"name":"Center for Medicinal Cannabis Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[{"name":"Institute for Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Center for Medicinal Cannabis Research, Department of Pathology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yoi230053r1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use: a review of recent findings.","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr Opin Psychol"},{"issue":"7","key":"yoi230053r2","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s11606-020-05800-7","article-title":"Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population.","volume":"35","author":"Azcarate","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"7","key":"yoi230053r3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition\u2014a systematic review.","volume":"79","author":"Broyd","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi230053r4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41583-021-00466-4","article-title":"The why behind the high: determinants of neurocognition during acute cannabis exposure.","volume":"22","author":"Ramaekers","year":"2021","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"yoi230053r5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2021.4037","article-title":"Driving performance and cannabis users\u2019 perception of safety: a randomized clinical trial.","volume":"79","author":"Marcotte","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi230053r6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15389580490465201","article-title":"Effects of alcohol and other drugs on driver performance.","volume":"5","author":"Ogden","year":"2004","journal-title":"Traffic Inj Prev"},{"issue":"4","key":"yoi230053r7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jat\/bky104","article-title":"Acute pharmacokinetic profile of smoked and vaporized cannabis in human blood and oral fluid.","volume":"43","author":"Spindle","year":"2019","journal-title":"J Anal Toxicol"},{"issue":"3","key":"yoi230053r8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1373\/clinchem.2012.195503","article-title":"Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers\u2019 blood on per se drugged driving laws.","volume":"59","author":"Bergamaschi","year":"2013","journal-title":"Clin Chem"},{"issue":"3 pt 2","key":"yoi230053r11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2466\/pms.2003.97.3f.1187","article-title":"An overview of field sobriety test research.","volume":"97","author":"Burns","year":"2003","journal-title":"Percept Mot Skills"},{"issue":"3","key":"yoi230053r12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1518\/001872006778606895","article-title":"Validation of the standardized field sobriety test battery at 0.08% blood alcohol concentration.","volume":"48","author":"Stuster","year":"2006","journal-title":"Hum Factors"},{"issue":"6","key":"yoi230053r13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/00952990.2019.1655568","article-title":"Strengths and limitations of two cannabis-impaired driving detection methods: a review of the literature.","volume":"45","author":"Ginsburg","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2-3","key":"yoi230053r14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.forsciint.2004.11.009","article-title":"The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.","volume":"155","author":"Papafotiou","year":"2005","journal-title":"Forensic Sci Int"},{"issue":"4","key":"yoi230053r15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00213-012-2732-y","article-title":"A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid.","volume":"223","author":"Bosker","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"yoi230053r16","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/jat.v37.8","article-title":"Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.","volume":"37","author":"Newmeyer","year":"2017","journal-title":"J Appl Toxicol"},{"issue":"6","key":"yoi230053r17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jat\/22.6.503","article-title":"Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana.","volume":"22","author":"Heishman","year":"1998","journal-title":"J Anal Toxicol"},{"issue":"4","key":"yoi230053r18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00213-012-2787-9","article-title":"Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests.","volume":"224","author":"Downey","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"yoi230053r19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/add.2012.107.issue-10","article-title":"Medicinal ?(9)-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.","volume":"107","author":"Bosker","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"yoi230053r21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00213-004-2119-9","article-title":"An evaluation of the sensitivity of the Standardised Field Sobriety Tests (SFSTs) to detect impairment due to marijuana intoxication.","volume":"180","author":"Papafotiou","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"20","key":"yoi230053r25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"yoi230053r26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/jat\/bkab078","article-title":"Blood and oral fluid cannabinoid profiles of frequent and occasional cannabis smokers.","volume":"45","author":"Hoffman","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"8","key":"yoi230053r27","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/jat\/bkab080","article-title":"Biomarkers of recent cannabis use in blood, oral fluid and breath.","volume":"45","author":"Hubbard","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"1","key":"yoi230053r28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12874-018-0530-x","article-title":"Correction for retest effects across repeated measures of cognitive functioning: a longitudinal cohort study of postoperative delirium.","volume":"18","author":"Racine","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"yoi230053r30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00213-012-2915-6","article-title":"Acute effects of THC on time perception in frequent and infrequent cannabis users.","volume":"226","author":"Sewell","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"yoi230053r31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.aap.2005.04.002","article-title":"Drug identification performance on the basis of observable signs and symptoms.","volume":"37","author":"Shinar","year":"2005","journal-title":"Accid Anal Prev"},{"key":"yoi230053r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107771","article-title":"Recreational cannabis use impairs driving performance in the absence of acute intoxication.","volume":"208","author":"Dahlgren","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"yoi230053r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2021.106326","article-title":"Simulated driving performance among daily and occasional cannabis users.","volume":"160","author":"Brooks-Russell","year":"2021","journal-title":"Accid Anal Prev"},{"issue":"21","key":"yoi230053r36","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1001\/jama.2020.21218","article-title":"Effect of cannabidiol and ?9-tetrahydrocannabinol on driving performance: a randomized clinical trial.","volume":"324","author":"Arkell","year":"2020","journal-title":"JAMA"},{"key":"yoi230053r37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drugalcdep.2015.06.015","article-title":"Cannabis effects on driving lateral control with and without alcohol.","volume":"154","author":"Hartman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"yoi230053r38","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvad054","article-title":"Driving under the influence of cannabis: impact of combining toxicology testing with field sobriety tests.","author":"Fitzgerald","journal-title":"Clin Chem"},{"issue":"4157","key":"yoi230053r39","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","article-title":"Judgment under uncertainty: heuristics and biases.","volume":"185","author":"Tversky","year":"1974","journal-title":"Science"},{"issue":"2","key":"yoi230053r40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1037\/1089-2680.2.2.175","article-title":"Confirmation bias: a ubiquitous phenomenon in many guises.","volume":"2","author":"Nickerson","year":"1998","journal-title":"Rev Gen Psychol"},{"issue":"2","key":"yoi230053r41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jarmac.2013.01.001","article-title":"The forensic confirmation bias: problems, perspectives and proposed solutions.","author":"Kassin","year":"2013","journal-title":"J Appl Res Mem Cogn"},{"issue":"6","key":"yoi230053r43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/arclin\/acw050","article-title":"Neuropsychological assessment of driving capacity.","volume":"31","author":"Wolfe","year":"2016","journal-title":"Arch Clin Neuropsychol"},{"key":"yoi230053r45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2016.08.001","article-title":"Sex-dependent effects of cannabis-induced analgesia.","volume":"167","author":"Cooper","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"yoi230053r46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.4841","article-title":"Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial.","volume":"1","author":"Spindle","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"yoi230053r47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/jat\/bkv012","article-title":"Smoked cannabis\u2019 psychomotor and neurocognitive effects in occasional and frequent smokers.","volume":"39","author":"Desrosiers","year":"2015","journal-title":"J Anal Toxicol"},{"key":"yoi230053r9"},{"key":"yoi230053r10","volume-title":"DWI Detection and Standardized Field Sobriety Testing: Administrator Guide","author":"National Highway Traffic Safety Administration","year":"2018"},{"key":"yoi230053r20"},{"key":"yoi230053r22","volume-title":"Thinking, Fast and Slow","author":"Kahneman","year":"2011"},{"key":"yoi230053r23","author":"National Academies of Sciences, Engineering","year":"2017"},{"key":"yoi230053r24","author":"Worden","year":"2020"},{"key":"yoi230053r34","author":"Mastropietro","year":"2022"},{"key":"yoi230053r42","year":"2009"},{"key":"yoi230053r44","volume-title":"Neuropsychology of Everyday Functioning","author":"Marcotte","year":"2022","edition":"2nd ed"},{"key":"yoi230053r48","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"yoi230053r29","unstructured":"Logan? BK, Kacinko? SL, Beirness? DJ. An evaluation of data from drivers arrested for driving under the influence in relation to per se limits for cannabis. AAA Foundation for Traffic Safety. 2016. Accessed February 16, 2022. https:\/\/aaafoundation.org\/wp-content\/uploads\/2017\/12\/EvaluationOfDriversInRelationToPerSeReport.pdf"},{"key":"yoi230053r35","unstructured":"Special Master Proceeding. State of New Jersey v Michael Olenowski (NJ Super Ct 2022). Accessed June 27, 2023. https:\/\/www.njcourts.gov\/press-releases\/2022\/08\/special-master-report-matter-state-new-jersey-v-michael-olenowski"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2807719\/jamapsychiatry_marcotte_2023_oi_230053_1693497154.9699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:06:37Z","timestamp":1694012797000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2807719"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.2345","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}